Recombinant Human BCMA (Z101445) by ABM. TNFRSF17/CD269, 6 kDa, >95% purity, E. coli. ED50 <0.05 ng/mL. Multiple myeloma target research, BAFF/APRIL binding, and B-cell biology. Available in 20 µg (Z101445), 100 µg (Z101447), 1.0 mg (Z101449).